HUBUNGAN TGF-β1 DAN ESTROGEN DENGAN VOLUME PROSTAT PADA PASIEN BPH, PASIEN TUA NON BPH, DAN PASIEN MUDA

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

PDF
Boyke Soebhali Soetojo Soetojo Doddy M Soebadi Hendromartono Hendromartono Widodo J P

Abstract

Objective: To determine the correlation of TGF-b1 and estrogen with prostate volume in BPH patients, old patients without BPH and young patients. Materials and methods: We enrolled 30 patients and allocated them into three groups. First group consists of BPH patients, second group consists of old male patients with more than 55 years of age, and third group consists of young male patients with less than 40 years of age. We analyzed the level of TGF-b1 and estrogen in these patients. Transrectal USG was used to measure the prostate volume. We analyzed the correlations of TGF-b1 and estrogen level with prostate volume. Results: We found a positive strong correlation between estrogen and prostate volume in the BPH patient group (p=0,021; r coeff=0,786). Other group showed no significant correlations. Conclusion: Estrogen plays an important role in BPH pathophysiology. Further research on the influence of estrogen in BPH patients is recommended.


##plugins.themes.bootstrap3.article.details##

Keywords

TGF-1, Estrogen, BPH

References

Presti JC. Neoplasms of the prostate gland. In: Tanagho EA, McAninch JW, editors. Smith’s General Urology 16th ed. New York: Lange Medical Books/Mc Graw-Hill; 2004. p. 367-85.

Wein AJ, Rovner ES. Benign prostatic hyperplasia. In: Hanno PM editors. Clinical Manual of Urology 3th ed. Boston Burr Ridge: Mc Graw-Hill; 2001. p. 437-70.

Roehrborn CG, McConnell JD. Etiology, pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. In: Walsh PC editors. Campbell’s Urology 8th ed. Philadelphia: Saunders; 2002. p. 1297-336.

Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F. Cross talk between transforming growth factor-beta and estrogen receptor signaling through smas-3. Department of Immunology, Faculty of Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan. J. Biol Chem 2001; 276 (46): 42908-14.

Story MT. Regulation of prostat growth by fibroblast growth factors. World J. Urol 1995; 13(5): 297-305.

Mc Connel JD, Roehrborn CG. Etiology, pathophysiology, and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein A eds. Campbell’s Urology 8th ed. Philadelphia: WB Saunders; 2002. p. 1297-330.

Griffiths K. Regulation of prostate growth. Molecular Biology of Prostate Cancer. Walter de Gruyter, Inc.; 1998. p. 208.

Soetojo. Pengaruh pemberian kombinasi 5 alfa reduktase inhibitor dan estrogen pada proliferasi jaringan prostat. Surabaya: Program Pascasarjana Universitas Airlangga; 2004. p. 91-101.

Lee C, Emberton M. Regulation of the prostate growth. In: Chatelain C editors. Benign Prostatic Hyperplasia. 5th International Consultation on Benign Prostatic Hyperplasia (BPH). Paris; 2000. United Kingdom: Health Publication Ltd; 2001. p. 81-99.

Winter ML, Liehr JC. Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs. Toxicology and Applied Pharmacology. Academic Press, Inc. 1996; 136 (2): 211-19.

Banerjee PP, Banerjee S, Brown TR. Increased androgen receptor expression correlates with development of age-dependent, lobe-specific spontaneous hyperplasia of the brown norway rat prostate. The Endocrine Society. Endocrinology 2002; 142 (9): 4066-75.

Partin AW, Hanks GE, Klein EA, Moul JW, Nelson WG, Scher HI. Prostate specific antigen as a marker of disease activity in prostate cancer. Oncology 2002; 16 (9): 1218-24.

Saez C, Gonzalez-Baena AC, Japon MA, Giraldez J, Segura DI, Miranda G, et al. Regressive changes in finasteride-treated human hyperplastic prostates correlates with an upregulation of TGF- receptor expression. Wiley-Liss, Inc, A Wiley Company. The Prostate 2008; 37 (2): 84-90.

Lucia MS, Sporn MB, Roberts AB, Stewart LV, David. The role of transforming growth factor-1, -2, and -3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells. Wiley-Liss, Inc, A Wiley Company. Journal of Cellular Physiology 2008; 175 (2): 1834-2192.

Section
Articles
Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University